[ALZN] YoY Quarter Result on 31-Jan-2017 [#Q3]

Stock
[ALZN] Alzamend Neuro, Inc.
Announcement Date
30-Jan-2017
Financial Year
2017
Quarter
31-Jan-2017 [#Q3]
Profit Trend
QoQ- -3.37%
YoY-
Quarter Report
ALZN's Result
ALZN's Financial Summary
View:
Show?
Quarter Result
31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 31/01/17 CAGR
Revenue 0 0 0 0 0 0 118 -
PBT -5,426 -2,573 -1,119 -1,271 -906 -327 -399 54.46%
Tax 2 33 -1,050 3 31 -0 -8 -
NP -5,428 -2,573 -1,119 -1,271 -906 -327 -399 54.47%
Tax Rate - - - - - - - -
Total Cost 5,428 2,573 1,119 1,271 906 327 518 47.90%
Ratio Analysis
31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 31/01/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -337.08 -
Per Share
31/01/23 31/01/22 31/01/21 31/01/20 31/01/19 31/01/18 31/01/17 CAGR
EPS -8.29 -4.10 -2.33 -2.67 -2.04 -0.85 -1.83 28.61%
EPS Diluted -8.28 -4.10 -2.32 -2.67 -2.04 -0.85 -1.83 28.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.